phacidin has been researched along with 2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one in 1 studies
| Studies (phacidin) | Trials (phacidin) | Recent Studies (post-2010) (phacidin) | Studies (2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one) | Trials (2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one) | Recent Studies (post-2010) (2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 11 | 0 | 5 |
| Protein | Taxonomy | phacidin (IC50) | 2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 100 | |
| integrase, partial | Human immunodeficiency virus 1 | 0.3409 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.3409 | |
| Vif | Human immunodeficiency virus 1 | 22.14 | |
| Tat | Human immunodeficiency virus 1 | 74.865 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 22.14 | |
| Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 | Homo sapiens (human) | 6 | |
| 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Homo sapiens (human) | 2.97 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorjsuren, D; Egli, M; Eoff, RL; Jadhav, A; Lloyd, RS; Maloney, DJ; Simeonov, A; Yamanaka, K | 1 |
1 other study(ies) available for phacidin and 2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one
| Article | Year |
|---|---|
A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ.
Topics: Acrolein; Benzimidazoles; Biphenyl Compounds; Cell Line, Transformed; Cell Survival; Deoxyguanosine; DNA; DNA Adducts; DNA Damage; DNA Repair; DNA-Directed DNA Polymerase; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Indoles; Nucleic Acid Synthesis Inhibitors; Small Molecule Libraries; Terpenes; Tetrazoles; Ultraviolet Rays | 2012 |